{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:04:04Z","timestamp":1780509844663,"version":"3.54.1"},"reference-count":94,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2026,5,10]]},"abstract":"<jats:p>Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and a leading preventable cause of ischaemic stroke, with rising prevalence and substantial healthcare burden worldwide. While cardiologists traditionally lead AF management, neurologists play a pivotal role given their expertise in diagnosing stroke, managing its secondary prevention and assessing the risk\u2013benefit of anticoagulation. In this narrative review, we summarise recent advances in AF management and their implications for neurology practice, underscoring the importance of proactive and collaborative management to reduce the burden of AF-related stroke.<\/jats:p>","DOI":"10.1136\/pn-2025-004712","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:20:18Z","timestamp":1780507218000},"page":"pn-2025-004712","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Atrial fibrillation"],"prefix":"10.1136","clinical-trial-number":[{"clinical-trial-number":"nct03642509","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Hizir","family":"Ozdemir","sequence":"first","affiliation":[{"name":"Department of Cardiology, Eskisehir Osmangazi University Faculty of Medicine, Eski\u015fehir, Eski\u015fehir Province, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-2944","authenticated-orcid":false,"given":"Gashirai K","family":"Mbizvo","sequence":"additional","affiliation":[{"name":"Liverpool Interdisciplinary Neuroscience Centre, University of Liverpool, Liverpool, England, UK"},{"name":"Liverpool Centre of Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, University of Liverpool, Liverpool, UK"},{"name":"Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK"},{"name":"Neurology Department, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8904-9331","authenticated-orcid":false,"given":"Mark","family":"Radon","sequence":"additional","affiliation":[{"name":"Neuroradiology Department, The Walton Centre NHS Foundation Trust, Liverpool, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"},{"name":"Department of Cardiology, Lipidology and Internal Medicine with Intensive Coronary Care Unit, Medical University of Bialystok, Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2026060310201266000_pn-2025-004712v1.1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2023.100786","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2026060310201266000_pn-2025-004712v1.2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjqcco\/qcaa061","article-title":"Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: results from the Global Burden of Disease Study 2017","volume":"7","author":"Dai","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026060310201266000_pn-2025-004712v1.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht280"},{"key":"2026060310201266000_pn-2025-004712v1.4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ehjqcco\/qcaa093","article-title":"Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs","volume":"8","author":"Burdett","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026060310201266000_pn-2025-004712v1.5","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.015071"},{"key":"2026060310201266000_pn-2025-004712v1.6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae150"},{"key":"2026060310201266000_pn-2025-004712v1.7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006070"},{"key":"2026060310201266000_pn-2025-004712v1.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313600"},{"key":"2026060310201266000_pn-2025-004712v1.9","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.008714"},{"key":"2026060310201266000_pn-2025-004712v1.10","doi-asserted-by":"crossref","DOI":"10.1177\/23969873221099478","article-title":"European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin","volume":"7","author":"Rubiera","year":"2022","journal-title":"Eur Stroke J"},{"key":"2026060310201266000_pn-2025-004712v1.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae176"},{"key":"2026060310201266000_pn-2025-004712v1.12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2024.10.100","article-title":"2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke: A Report of the American College of Cardiology Solution Set Oversight Committee","volume":"85","author":"Spooner","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026060310201266000_pn-2025-004712v1.13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaneurol.2025.1337","article-title":"Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis","volume":"82","author":"McCabe","year":"2025","journal-title":"JAMA Neurol"},{"key":"2026060310201266000_pn-2025-004712v1.14","first-page":"625","article-title":"Barriers to Guideline-Directed Anticoagulation in Patients With Atrial Fibrillation: New Approaches to an Old Problem","volume":"39","author":"Bhat","year":"2023","journal-title":"Can J Cardiol"},{"key":"2026060310201266000_pn-2025-004712v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2020.07.012"},{"key":"2026060310201266000_pn-2025-004712v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.153"},{"key":"2026060310201266000_pn-2025-004712v1.17","first-page":"764","article-title":"A Novel Model of Integrated Care of Older Patients With Atrial Fibrillation in Rural China","volume":"4","author":"Li","year":"2024","journal-title":"JACC: Asia"},{"key":"2026060310201266000_pn-2025-004712v1.18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0043-1772773","article-title":"Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry","volume":"124","author":"Treewaree","year":"2024","journal-title":"Thromb Haemost"},{"key":"2026060310201266000_pn-2025-004712v1.19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1055\/s-0043-1769612","article-title":"Mobile Health-Technology-Integrated Care for Atrial Fibrillation: A Win Ratio Analysis from the mAFA-II Randomized Clinical Trial","volume":"123","author":"Romiti","year":"2023","journal-title":"Thromb Haemost"},{"key":"2026060310201266000_pn-2025-004712v1.20","doi-asserted-by":"publisher","DOI":"10.1055\/a-1515-9630"},{"key":"2026060310201266000_pn-2025-004712v1.21","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1055\/a-2595-5575","article-title":"Patient Care Pathways and Risk Assessments in Patients with Atrial Fibrillation: A Comparison of Asian versus Non-Asian Cohorts","volume":"125","author":"Chang","year":"2025","journal-title":"Thromb Haemost"},{"key":"2026060310201266000_pn-2025-004712v1.22","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology Guidelines for Diagnosis and Management of Atrial Fibrillation: A Viewpoint from a Practicing Clinician\u2019s Perspective","volume":"124","author":"Potpara","year":"2024","journal-title":"Thromb Haemost"},{"key":"2026060310201266000_pn-2025-004712v1.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2023.100797","article-title":"Atrial fibrillation: stroke prevention","volume":"37","author":"Chao","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2026060310201266000_pn-2025-004712v1.24","doi-asserted-by":"crossref","unstructured":"Son MK , Lim N-K , Kim HW , et al . Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort. PLoS One 2017;12. doi:10.1371\/journal.pone.0179687","DOI":"10.1371\/journal.pone.0179687"},{"key":"2026060310201266000_pn-2025-004712v1.25","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.27.10.1760"},{"key":"2026060310201266000_pn-2025-004712v1.26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584"},{"key":"2026060310201266000_pn-2025-004712v1.27","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1675400"},{"key":"2026060310201266000_pn-2025-004712v1.28","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041234","article-title":"Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis","volume":"9","author":"Fauchier","year":"2020","journal-title":"J Clin Med"},{"key":"2026060310201266000_pn-2025-004712v1.29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/FJC.0000000000000750","article-title":"Should We Judge Stroke Risk by Static or Dynamic Risk Scores? A Focus on the Dynamic Nature of Stroke and Bleeding Risks in Patients With Atrial Fibrillation","volume":"74","author":"Domek","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026060310201266000_pn-2025-004712v1.30","doi-asserted-by":"crossref","unstructured":"Shantsila E , Choi E-K , Lane DA , et al . Atrial fibrillation: comorbidities, lifestyle, and patient factors. Lancet Reg Health Eur 2024;37. doi:10.1016\/j.lanepe.2023.100784","DOI":"10.1016\/j.lanepe.2023.100784"},{"key":"2026060310201266000_pn-2025-004712v1.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308398"},{"key":"2026060310201266000_pn-2025-004712v1.32","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1093\/eurheartj\/ehab597","article-title":"Day-to-day measurement of physical activity and risk of atrial fibrillation","volume":"42","author":"Bonnesen","year":"2021","journal-title":"Eur Heart J"},{"key":"2026060310201266000_pn-2025-004712v1.33","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/eurheartj\/ehaa032","article-title":"Physical activity, cardiorespiratory fitness, and cardiovascular outcomes in individuals with atrial fibrillation: the HUNT study","volume":"41","author":"Garnvik","year":"2020","journal-title":"Eur Heart J"},{"key":"2026060310201266000_pn-2025-004712v1.34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018220"},{"key":"2026060310201266000_pn-2025-004712v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.07.060"},{"key":"2026060310201266000_pn-2025-004712v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.08.074"},{"key":"2026060310201266000_pn-2025-004712v1.37","doi-asserted-by":"crossref","unstructured":"Bodar V , Chen J , Gaziano JM , et al . Coffee Consumption and Risk of Atrial Fibrillation in the Physicians\u2019 Health Study. JAHA 2019;8. doi:10.1161\/JAHA.118.011346","DOI":"10.1161\/JAHA.118.011346"},{"key":"2026060310201266000_pn-2025-004712v1.38","unstructured":"National Guideline C . Anticoagulant therapy for stroke prevention in people with atrial fibrillation: atrial fibrillation: diagnosis and management: evidence review g1. London National Institute for Health and Care Excellence (NICE) Copyright \u00a9 NICE 2021; 2021."},{"key":"2026060310201266000_pn-2025-004712v1.39","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193"},{"key":"2026060310201266000_pn-2025-004712v1.40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.115410"},{"key":"2026060310201266000_pn-2025-004712v1.41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038736","article-title":"Anticoagulation in Atrial Fibrillation With Valvular Heart Disease","volume":"14","author":"Fonseca","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026060310201266000_pn-2025-004712v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"2026060310201266000_pn-2025-004712v1.43","doi-asserted-by":"publisher","DOI":"10.7326\/M22-0511"},{"key":"2026060310201266000_pn-2025-004712v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(18)30356-9"},{"key":"2026060310201266000_pn-2025-004712v1.45","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002430","article-title":"Predicting Hemorrhagic Transformation of Acute Ischemic Stroke: Prospective Validation of the HeRS Score","volume":"95","author":"Marsh","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2026060310201266000_pn-2025-004712v1.46","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab065"},{"key":"2026060310201266000_pn-2025-004712v1.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303048"},{"key":"2026060310201266000_pn-2025-004712v1.48","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.060666"},{"key":"2026060310201266000_pn-2025-004712v1.49","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(24)02197-4","article-title":"Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial","volume":"404","author":"Werring","year":"2024","journal-title":"The Lancet"},{"key":"2026060310201266000_pn-2025-004712v1.50","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jamaneurol.2023.3931","article-title":"Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease: 3-Year Results From the STROKE AF Randomized Clinical Trial","volume":"80","author":"Bernstein","year":"2023","journal-title":"JAMA Neurol"},{"key":"2026060310201266000_pn-2025-004712v1.51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/17474930241292988","article-title":"Detection of atrial fibrillation after stroke due to large or small vessel disease: Systematic review and meta-analysis","volume":"20","author":"Florentin","year":"2025","journal-title":"Int J Stroke"},{"key":"2026060310201266000_pn-2025-004712v1.52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/cvr\/cvad135","article-title":"Stroke risk management in carotid atherosclerotic disease: a clinical consensus statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases","volume":"121","author":"Musialek","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026060310201266000_pn-2025-004712v1.53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ehjqcco\/qcad019","article-title":"Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study","volume":"10","author":"Grymonprez","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026060310201266000_pn-2025-004712v1.54","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamacardio.2024.1793","article-title":"Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial","volume":"9","author":"Zimerman","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2026060310201266000_pn-2025-004712v1.55","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031506","article-title":"Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial","volume":"13","author":"Akao","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026060310201266000_pn-2025-004712v1.56","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.106500"},{"key":"2026060310201266000_pn-2025-004712v1.57","doi-asserted-by":"crossref","unstructured":"Hankey GJ GJ , Stevens SR SR , Piccini JP JP , et al . Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke 2014. doi:10.1161\/STROKEAHA.113.004506","DOI":"10.1161\/STROKEAHA.113.004506"},{"key":"2026060310201266000_pn-2025-004712v1.58","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.650614"},{"key":"2026060310201266000_pn-2025-004712v1.59","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","article-title":"Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial","volume":"405","author":"Veltkamp","year":"2025","journal-title":"Lancet"},{"key":"2026060310201266000_pn-2025-004712v1.60","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00315-0"},{"key":"2026060310201266000_pn-2025-004712v1.61","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1212\/01.wnl.0000435298.80023.7a","article-title":"Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy","volume":"81","author":"Charidimou","year":"2013","journal-title":"Neurology (ECronicon)"},{"key":"2026060310201266000_pn-2025-004712v1.62","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/WNL.0000000000003281","article-title":"Cortical superficial siderosis predicts early recurrent lobar hemorrhage","volume":"87","author":"Roongpiboonsopit","year":"2016","journal-title":"Neurology (ECronicon)"},{"key":"2026060310201266000_pn-2025-004712v1.63","first-page":"e2192","article-title":"Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy","volume":"93","author":"Charidimou","year":"2019","journal-title":"Neurology (ECronicon)"},{"key":"2026060310201266000_pn-2025-004712v1.64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/23969873241296803","article-title":"Oral Anticoagulation following intracranial haemorrhage in patients with atrial fibrillation","volume":"10","author":"Shoamanesh","year":"2025","journal-title":"Eur Stroke J"},{"key":"2026060310201266000_pn-2025-004712v1.65","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/03080226231188020","article-title":"National Clinical Guideline for Stroke for the United Kingdom and Ireland: Part I - An overview of the updated recommendations","volume":"86","author":"Crow","year":"2023","journal-title":"Br J Occup Ther"},{"key":"2026060310201266000_pn-2025-004712v1.66","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/a-2469-4896","article-title":"An International Consensus Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician: Executive Summary","volume":"125","author":"Potpara","year":"2025","journal-title":"Thromb Haemost"},{"key":"2026060310201266000_pn-2025-004712v1.67","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.027815"},{"key":"2026060310201266000_pn-2025-004712v1.68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jad.2024.01.224","article-title":"Atrial fibrillation increases the risk of all-cause dementia, Alzheimer\u2019s disease, and vascular dementia: A cohort study of 373, 415 participants in the UK Biobank","volume":"351","author":"Zhai","year":"2024","journal-title":"J Affect Disord"},{"key":"2026060310201266000_pn-2025-004712v1.69","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14154","article-title":"The association between atrial fibrillation and dementia: A uk linked electronic health records cohort study","volume":"54","author":"Brooks","year":"2024","journal-title":"Eur J Clin Investigation"},{"key":"2026060310201266000_pn-2025-004712v1.70","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.121.055018"},{"key":"2026060310201266000_pn-2025-004712v1.71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/a-2184-7506","article-title":"Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia","volume":"124","author":"Tsai","year":"2024","journal-title":"Thromb Haemost"},{"key":"2026060310201266000_pn-2025-004712v1.72","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-328391"},{"key":"2026060310201266000_pn-2025-004712v1.73","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/ehad200","article-title":"Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation","volume":"44","author":"Benz","year":"2023","journal-title":"Eur Heart J"},{"key":"2026060310201266000_pn-2025-004712v1.74","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.025350"},{"key":"2026060310201266000_pn-2025-004712v1.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.07.022"},{"key":"2026060310201266000_pn-2025-004712v1.76","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12185784","article-title":"Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation","volume":"12","author":"Galea","year":"2023","journal-title":"J Clin Med"},{"key":"2026060310201266000_pn-2025-004712v1.77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044959","article-title":"Clues to Occult Cancer in Patients with Ischemic Stroke","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS ONE"},{"key":"2026060310201266000_pn-2025-004712v1.78","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000665"},{"key":"2026060310201266000_pn-2025-004712v1.79","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000375"},{"key":"2026060310201266000_pn-2025-004712v1.80","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023391","article-title":"Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial)","volume":"11","author":"Park","year":"2022","journal-title":"JAHA"},{"key":"2026060310201266000_pn-2025-004712v1.81","article-title":"Outcomes of Early Rhythm Control Therapy in Patients With Atrial Fibrillation and a High Comorbidity Burden in Large Real-World Cohorts","volume":"16","author":"Dickow","year":"2023","journal-title":"Circ: Arrhythmia and Electrophysiology"},{"key":"2026060310201266000_pn-2025-004712v1.82","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407105"},{"key":"2026060310201266000_pn-2025-004712v1.83","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.016990"},{"key":"2026060310201266000_pn-2025-004712v1.84","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1161\/STROKEAHA.124.044293","article-title":"Cerebral Amyloid Angiopathy","volume":"55","author":"Greenberg","year":"2024","journal-title":"Stroke"},{"key":"2026060310201266000_pn-2025-004712v1.85","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.000038"},{"key":"2026060310201266000_pn-2025-004712v1.86","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-015-0524-7","article-title":"Anticoagulation for Atrial Fibrillation in Patients with Cerebral Microbleeds","volume":"17","author":"Wilson","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"2026060310201266000_pn-2025-004712v1.87","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.031031"},{"key":"2026060310201266000_pn-2025-004712v1.88","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/STROKEAHA.123.044167","article-title":"Cardiovascular Management in Asymptomatic (Silent) Cerebral Microbleeds and Suspected Cerebral Amyloid Angiopathy","volume":"55","author":"Charidimou","year":"2024","journal-title":"Stroke"},{"key":"2026060310201266000_pn-2025-004712v1.89","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30231-5"},{"key":"2026060310201266000_pn-2025-004712v1.90","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.668533"},{"key":"2026060310201266000_pn-2025-004712v1.91","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032910","article-title":"Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta-Analysis, and Network Meta-Analysis","volume":"13","author":"Musmar","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026060310201266000_pn-2025-004712v1.92","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2025.1577820","article-title":"Antithrombotic therapy and cavernoma bleeding: does vascular border zone localization matter?","volume":"12","author":"Guranda","year":"2025","journal-title":"Front Surg"},{"key":"2026060310201266000_pn-2025-004712v1.93","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1055\/a-2259-1134","article-title":"Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation","volume":"8","author":"Bhagirath","year":"2024","journal-title":"TH Open"},{"key":"2026060310201266000_pn-2025-004712v1.94","doi-asserted-by":"crossref","first-page":"123044","DOI":"10.1016\/j.jns.2024.123044","article-title":"Cerebral cavernous malformations \u2013 An overview on genetics, clinical aspects and therapeutic strategies","volume":"461","author":"Dulamea","year":"2024","journal-title":"J Neurol Sci"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/pn-2025-004712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:20:27Z","timestamp":1780507227000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/pn-2025-004712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":94,"alternative-id":["10.1136\/pn-2025-004712"],"URL":"https:\/\/doi.org\/10.1136\/pn-2025-004712","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}